Meropenem Eberth

Meropenem, the active ingredient in Meropenem Eberth, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections, including intra‑abdominal, urinary tract, and respiratory infections, in hospitalized adults and children. The product conforms to EU quality standards and is marketed across European Union countries.

GNH USA supplies Meropenem Eberth as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is used to treat serious infections caused by susceptible bacteria, particularly in hospital settings.

- Complicated intra‑abdominal infection: provides broad coverage against mixed aerobic and anaerobic pathogens to resolve infection. - Hospital‑acquired pneumonia/ventilator‑associated pneumonia: achieves bacterial eradication in the lungs. - Complicated urinary tract infection: eliminates resistant Gram‑negative organisms in the urinary tract. - Bacterial meningitis: penetrates the cerebrospinal fluid to treat central nervous system infections. - Sepsis and febrile neutropenia: offers rapid bactericidal activity in systemic infections.

Adverse reactions to Meropenem may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: may be watery or loose. - Headache: transient cranial discomfort. - Rash: skin redness or itching. - Elevated liver enzymes: mild hepatic enzyme rise.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile‑associated diarrhea: severe colitis risk. - Anaphylaxis: acute allergic reaction requiring immediate care. - Severe neutropenia: marked decrease in white blood cells. - Renal impairment: worsening kidney function in susceptible individuals.

When using Meropenem, clinicians should consider several safety and monitoring factors.

- Renal function: adjust dose in patients with impaired clearance. - Hypersensitivity: discontinue if allergic reaction occurs. - Seizure risk: monitor patients with central nervous system disorders. - Concomitant valproic acid: may reduce serum levels; consider alternative therapy. - Antimicrobial stewardship: limit use to confirmed infections to prevent resistance. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem can affect or be affected by other medicines; awareness of key interactions helps prevent complications.

Major Interactions (Avoid): - Valproic acid: reduced plasma concentrations; avoid co‑administration. - Probenecid: increased meropenem levels; monitor renal function. - High‑dose aminoglycosides: enhanced nephrotoxicity; monitor kidney function.

Moderate Interactions (Monitor Closely): - NSAIDs: potential renal effects; monitor creatinine. - Oral contraceptives: reduced efficacy reported; consider alternative contraception. - Other antibiotics: possible antagonism; assess clinical need.